Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type a receptors as fast acting treatment for depression and mood disorders

Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type a receptors as fast acting treatment for depression and mood disorders

US Patent 11897875 · Granted Feb 13, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 62025
Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 62025
Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 62023
Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 62023
Substituted Imidazo[1,2-a]-pyridines as IRAK 1/4 and FLT3 inhibitors2023
Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-amin2022
Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-amin2022
Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-amin2022
Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-amin2022
Substituted imidazo[1,2-A]pyridines as IRAK 1/4 and flt3 inhibitors2022
Process for synthesis and purification of (2R,6R)-hydroxynorketamine2021
Process for synthesis and purification of (2R,6R)-hydroxynorketamine2021